These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36895992)

  • 1. The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer.
    Aloliqi AA; Fararjeh AF; Al-Khader A; Kaddumi E; Eisa AA; Jaradat W
    World J Oncol; 2023 Feb; 14(1):84-93. PubMed ID: 36895992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.
    Lan T; Wang Y; Miao J; Guo H; Wang Z; Wang J; Zhang C; Yang P; Zhang Z; Dunmall LC; Wang Y
    Front Mol Biosci; 2022; 9():887059. PubMed ID: 35903153
    [No Abstract]   [Full Text] [Related]  

  • 3. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
    Guo Y; Luo W; Huang S; Zhao W; Chen H; Ma Y; Ye M; Nie Y; Zhang Y; Huang C; Zhou Q; He X; Chen M
    J Hepatocell Carcinoma; 2021; 8():871-885. PubMed ID: 34377684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
    Zhao H; Xie R; Zhang C; Lu G; Kong H
    Front Genet; 2022; 13():989460. PubMed ID: 36159971
    [No Abstract]   [Full Text] [Related]  

  • 5. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
    Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
    J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
    Chen X; Yuan Y; Zhou F; Huang X; Pu J; Niu X; Jiang X; Ding X
    Aging (Albany NY); 2022 Sep; 14(19):7866-7876. PubMed ID: 36170019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
    Zhang Y; Wang H; Liu Y; Yang J; Zuo X; Dong M; Zhang Z; Shi Y; Deng X; Lv Y
    Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36094557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle.
    Zhou T; Qin R; Shi S; Zhang H; Niu C; Ju G; Miao S
    Cell Cycle; 2021 Sep; 20(17):1681-1691. PubMed ID: 34369850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
    Sun F; Liu Y; Gong T; Pan Q; Xiang T; Zhao J; Tang Y; Chen H; Han Y; Song M; Huang Y; Li H; Chen Y; Yang C; Yang J; Wang Q; Li Y; He J; Weng D; Peng R; Xia J
    Cell Death Dis; 2021 Nov; 12(12):1093. PubMed ID: 34795209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation.
    Biswas P; Dey D; Rahman A; Islam MA; Susmi TF; Kaium MA; Hasan MN; Rahman MDH; Mahmud S; Saleh MA; Paul P; Rahman MR; Al Saber M; Song H; Rahman MA; Kim B
    J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
    Zhang J; Liu W; Feng S; Zhong B
    World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving landscape of involvement of DTYMK enzymes in cancer.
    Heydari N; Mahdizadeh M; Jafari SM
    Med Oncol; 2023 Jun; 40(8):213. PubMed ID: 37358701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
    Yong L; YuFeng Z; Guang B
    Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TUSC3 and its prognostic significance in colorectal cancer.
    Zhu YF; Dong M
    Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
    Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
    Front Genet; 2022; 13():783016. PubMed ID: 35281827
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression status of four mismatch repair proteins in patients with colorectal cancer: clinical significance in 1238 cases.
    Chen L; Chen G; Zheng X; Chen Y
    Int J Clin Exp Pathol; 2019; 12(10):3685-3699. PubMed ID: 31933757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of SPARC expression in non-small cell lung cancer: A meta-analysis and bioinformatics analysis.
    Ma GY; Shi S; Zhang YR; Guo ZB; Bai WW; Zhang ZG
    Oncol Lett; 2022 Nov; 24(5):412. PubMed ID: 36245823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
    Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.